AIM ImmunoTech (AIM) Debt to Equity (2018 - 2024)
Historic Debt to Equity for ImmunoTech (AIM) over the last 7 years, with Q3 2024 value amounting to $0.05.
- ImmunoTech's Debt to Equity changed N/A to $0.05 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.05, marking a year-over-year change of. This contributed to the annual value of $0.32 for FY2019, which is 3431.95% down from last year.
- As of Q3 2024, ImmunoTech's Debt to Equity stood at $0.05.
- ImmunoTech's Debt to Equity's 5-year high stood at $0.2 during Q1 2024, with a 5-year trough of $0.04 in Q3 2020.